Teri Loxam
2019
In 2019, Teri Loxam earned a total compensation of $1.8M as Chief Financial Officer at SQZ Biotechnologies Co.
Compensation breakdown
| Bonus | $125,000 |
|---|---|
| Non-Equity Incentive Plan | $140,000 |
| Option Awards | $1,376,804 |
| Salary | $130,513 |
| Other | $35,006 |
| Total | $1,807,323 |
Loxam received $1.4M in option awards, accounting for 76% of the total pay in 2019.
Loxam also received $125K in bonus, $140K in non-equity incentive plan, $130.5K in salary and $35K in other compensation.
Rankings
In 2019, Teri Loxam's compensation ranked 6,434th out of 13,971 executives tracked by ExecPay. In other words, Loxam earned more than 53.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,434 out of 13,971 | 54th |
Division Manufacturing | 2,433 out of 5,701 | 57th |
Major group Chemicals And Allied Products | 891 out of 2,200 | 60th |
Industry group Drugs | 756 out of 1,886 | 60th |
Industry Biological Products, Except Diagnostic Substances | 182 out of 389 | 53rd |
Source: SEC filing on April 26, 2021.
Loxam's colleagues
We found two more compensation records of executives who worked with Teri Loxam at SQZ Biotechnologies Co in 2019.